Top Markets
#1 Black Phoenix Black Phoenix +737.06%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.03%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +18.54%
#4 MetaDAO MetaDAO +15.56%
#5 Verus Coin Verus Coin +13.88%
#6 THORChain THORChain +10.94%
#7 The Bitcoin Bull The Bitcoin Bull +9.93%
#8 TENDIES TENDIES +9.88%
#9 PondCoin PondCoin +8.82%
#10 Akedo Akedo +8.29%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Rang in Aktien #4906
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Aktienkurs
$3.47
Marktkapitalisierung
$3.19B
Veränderung (1 Tag)
0.34%
Veränderung (1 Jahr)
-51.18%
Land
CN
Handel Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Kategorie

Healthcare
EPS für Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Hebei Changshan Biochemical Pharmaceutical Co., Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Hebei Changshan Biochemical Pharmaceutical Co., Ltd. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH